DK1200446T3 - Oxathiepino[6,5-b]dihydropyridiner og beslægtede forbindelser og fremgangsmåder - Google Patents

Oxathiepino[6,5-b]dihydropyridiner og beslægtede forbindelser og fremgangsmåder

Info

Publication number
DK1200446T3
DK1200446T3 DK00953634T DK00953634T DK1200446T3 DK 1200446 T3 DK1200446 T3 DK 1200446T3 DK 00953634 T DK00953634 T DK 00953634T DK 00953634 T DK00953634 T DK 00953634T DK 1200446 T3 DK1200446 T3 DK 1200446T3
Authority
DK
Denmark
Prior art keywords
oxathiepino
dihydropyridines
methods
related compounds
compounds
Prior art date
Application number
DK00953634T
Other languages
English (en)
Inventor
John H Dodd
James R Henry
Kenneth C Rupert
Daniel A Hall
James L Bullington
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1200446T3 publication Critical patent/DK1200446T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK00953634T 1999-07-12 2000-06-23 Oxathiepino[6,5-b]dihydropyridiner og beslægtede forbindelser og fremgangsmåder DK1200446T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14335499P 1999-07-12 1999-07-12
PCT/US2000/017310 WO2001004124A1 (en) 1999-07-12 2000-06-23 OXATHIEPINO[6,5-b]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS

Publications (1)

Publication Number Publication Date
DK1200446T3 true DK1200446T3 (da) 2005-10-24

Family

ID=22503704

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00953634T DK1200446T3 (da) 1999-07-12 2000-06-23 Oxathiepino[6,5-b]dihydropyridiner og beslægtede forbindelser og fremgangsmåder

Country Status (22)

Country Link
US (1) US6476022B1 (da)
EP (1) EP1200446B1 (da)
JP (1) JP2003504373A (da)
KR (1) KR20020012308A (da)
CN (1) CN1188416C (da)
AR (1) AR030396A1 (da)
AT (1) ATE302206T1 (da)
AU (1) AU779498B2 (da)
BR (1) BR0012386A (da)
CA (1) CA2379199A1 (da)
CZ (1) CZ2002126A3 (da)
DE (1) DE60022056T2 (da)
DK (1) DK1200446T3 (da)
ES (1) ES2246248T3 (da)
HK (1) HK1045506B (da)
HU (1) HUP0202265A3 (da)
IL (2) IL147540A0 (da)
MX (1) MXPA02000436A (da)
PL (1) PL352760A1 (da)
RU (1) RU2257388C2 (da)
TW (1) TWI256394B (da)
WO (1) WO2001004124A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200503733A (en) * 2003-03-28 2005-02-01 Nissan Chemical Ind Ltd T-shaped channel blockers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA429975A (en) 1945-09-11 F. D'alelio Gaetano Triazine derivative
US4483985A (en) 1978-10-31 1984-11-20 Bayer Aktiengesellschaft Production of 1,4-dihydropyridinecarboxylic acids
US4285955A (en) 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
NZ201395A (en) 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS58201764A (ja) 1982-05-17 1983-11-24 Maruko Seiyaku Kk ジヒドロピリジン誘導体
JPS6139760A (ja) 1984-07-31 1986-02-25 Toshiba Electric Equip Corp 集合住宅用インタ−ホン装置
JPS62253161A (ja) 1986-01-29 1987-11-04 Fuji Photo Film Co Ltd カラ−画像形成法
US4845225A (en) 1986-04-09 1989-07-04 Ortho Pharmaceutical Corporation Substituted thiacycloalkeno [3,2-b] pyridines
US4777167A (en) 1986-04-09 1988-10-11 Ortho Pharmaceutical Corporation Pharmaceutically useful substituted thiacycloalkeno [3,2-b]pyridines, compositions and method of use
US4879384A (en) 1988-06-15 1989-11-07 Ortho Pharmaceutical Corporation Preparation of thiocycloalkno [3,2-b] pyridines
US5075440A (en) 1990-05-03 1991-12-24 Ortho Pharmaceutical Corporation Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines
DE19532320A1 (de) 1995-09-01 1997-03-06 Bayer Ag Verfahren zur Herstellung von optisch aktiven ortho-substituierten 4-Aryl-Dihydropyridinen
HUP0201566A3 (en) * 1999-06-14 2004-03-01 Ortho Mcneil Pharm Inc Dithiepino[6,5-b]pyridines, their preparation pharmaceutical compositions containing thereof and an apparatus for their administering

Also Published As

Publication number Publication date
CN1372563A (zh) 2002-10-02
CN1188416C (zh) 2005-02-09
HUP0202265A2 (en) 2002-10-28
BR0012386A (pt) 2002-05-28
KR20020012308A (ko) 2002-02-15
ES2246248T3 (es) 2006-02-16
HK1045506A1 (en) 2002-11-29
RU2257388C2 (ru) 2005-07-27
US6476022B1 (en) 2002-11-05
ATE302206T1 (de) 2005-09-15
HUP0202265A3 (en) 2004-12-28
IL147540A0 (en) 2002-08-14
EP1200446A1 (en) 2002-05-02
IL147540A (en) 2006-12-10
MXPA02000436A (es) 2002-10-11
WO2001004124A1 (en) 2001-01-18
DE60022056D1 (de) 2005-09-22
AU6605000A (en) 2001-01-30
AU779498B2 (en) 2005-01-27
JP2003504373A (ja) 2003-02-04
AR030396A1 (es) 2003-08-20
PL352760A1 (en) 2003-09-08
CA2379199A1 (en) 2001-01-18
CZ2002126A3 (cs) 2003-04-16
EP1200446B1 (en) 2005-08-17
DE60022056T2 (de) 2006-06-08
HK1045506B (zh) 2006-02-03
TWI256394B (en) 2006-06-11

Similar Documents

Publication Publication Date Title
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
DK1163244T3 (da) Thienopyrimidinforbindelser, fremstilling og anvendelse heraf
EE04964B1 (et) Imidaso[1,2a]pridiini ja prasolo[2,3a]pridiiniderivaadid
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
DE60036746D1 (de) Analysator
DE60028849D1 (de) Sterilisationsmethode
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
ID26743A (id) Turunan 1,2,4,5-tetrahidro-benzo [d] azepin
EP1223932A4 (en) COMPOUNDS AND METHODS
EP1146790A4 (en) COMPOUNDS AND METHODS
IS2076B (is) Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
NO20015235D0 (no) 1-aminotriazolo [4,3-a]quinazolin-5-oner og/eller -5-tioner, inhiberende fosfodiesteraser
NO20013237D0 (no) 3,3-biarylpiperidin og 2,2-biarylmorfolinderivater
NO20020156D0 (no) Titanavledede forbindelser, fremstilling og anvendelse derav
PL344390A1 (en) Method of obtaining derivatives of 1,4-dihydropyridine
DK1627631T3 (da) Morfinsulfatmikrogranuler, fremgangsmåde til fremstilling deraf og præparat omfattende samme
AR025731A1 (es) "ditiepino [6,5-b] piridinas benzo-fusionadas y composiciones y metodos relacionados"
DE50009171D1 (de) Co 2 - kompressor
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
DK1192163T3 (da) Dithiepino[6,5-b]pyriner, beslægtede præparater og fremgangsmåder
NO20014393D0 (no) 1,3,4-oksadiazol-derivater og fremgangsmåte for fremstilling av disse
DK1200446T3 (da) Oxathiepino[6,5-b]dihydropyridiner og beslægtede forbindelser og fremgangsmåder
AU4732001A (en) Thiepino (3,2-b) dihydropyridines and related compositions and methods